MAP3K1 and ovarian carcinoma: Kanchi et al.22, using data from 429 serous ovarian carcinoma TCGA cases and 557 controls, identified several genes enriched for germline deleterious variants that were not previously associated with ovarian carcinoma (e.g. ASXL1, MAP3K1 and SETD2).